Yixintang Pharmaceutical Group Co., Ltd.

XSEC:002727 Stock Report

Market Cap: CN¥7.2b

Yixintang Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 002727?
Owner TypeNumber of SharesOwnership Percentage
Public Companies30,880,3045.26%
Institutions113,562,38319.3%
General Public191,825,84832.7%
Individual Insiders251,055,59042.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 66.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31%
Hong Xian Ruan
182,245,290CN¥2.2b0%no data
11.5%
Qiong Liu
67,505,100CN¥824.2m0%no data
5.26%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
30,880,304CN¥377.0m0%no data
3.93%
Rongtong Fund Management Co. Ltd.
23,069,953CN¥281.7m0%1.03%
3.06%
CIB Fund Management Co., Ltd
17,963,600CN¥219.3m0%1.92%
2.29%
Fidelity International Ltd
13,447,554CN¥164.2m0%0.01%
1.52%
UBS SDIC Fund Management Co., Ltd.
8,908,381CN¥108.8m0%0.37%
1.24%
Zhong Ou Fund Management Co., Ltd
7,295,544CN¥89.1m0%0.05%
1.13%
Dajia Asset Management Co., Ltd.
6,653,979CN¥81.2m0%0.21%
0.82%
Caitong Securities Asset Management Co.,Ltd
4,800,000CN¥58.6m0%0.65%
0.72%
First Seafront Fund Management Co., Ltd
4,226,820CN¥51.6m0%0.1%
0.68%
Fullgoal Fund Management Co. Ltd.
3,979,500CN¥48.6m0%0.02%
0.58%
Essence Fund Management Co., Ltd
3,393,746CN¥41.4m0%0.18%
0.52%
Penghua Fund Management Co., Ltd.
3,045,400CN¥37.2m0%0.03%
0.37%
GF Fund Management Co., Ltd.
2,156,440CN¥26.3m0%0.01%
0.34%
HSBC Jintrust Fund Management Company Limited
1,986,188CN¥24.3m0%0.1%
0.24%
Dimensional Fund Advisors LP
1,415,925CN¥17.3m13.6%no data
0.24%
The Vanguard Group, Inc.
1,396,033CN¥17.0m0%no data
0.2%
Great Wall Fund Management Co., Ltd
1,199,400CN¥14.6m0%0.06%
0.18%
China Southern Asset Management Co., Ltd.
1,039,000CN¥12.7m0%no data
0.16%
China Asset Management Co. Ltd.
955,921CN¥11.7m0%no data
0.14%
Taikang Asset Management Co., Ltd.
842,200CN¥10.3m0%0.03%
0.098%
Wanjia Asset Management Co., Ltd.
578,100CN¥7.1m0%0.01%
0.091%
KBC Asset Management NV
534,438CN¥6.5m0%no data
0.071%
CCB Principal Asset Management Co., Ltd.
418,400CN¥5.1m0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 13:38
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yixintang Pharmaceutical Group Co., Ltd. is covered by 19 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Haigang ChenChina International Capital Corporation Limited
Feifei XuChina Merchants Securities Co. Ltd.
Zhu ChenCitic Securities Co., Ltd.